PharmaShots | Incisive News in 3 Shots

Subscribe Now

GnRH Receptor Antagonist

Myovant's Orgovyx (relugolix) Receives the US FDA's Approval as the First Oral GnRH Receptor Antagonist for Advanced Prostate Cancer

Myovant's Orgovyx (relugolix) Receives the US FDA's Approval as the First Oral GnRH Receptor Antagonist for Advanced Prostate Canc...

December 15, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us